Journal profile · Psychiatry
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
ISSN 0013-7006 · eISSN 2589-4935 · Elsevier Masson · FRANCE · Bimonthly · Founded 1906
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.18; hybrid open access; APC about USD 2,240; median 102 days to acceptance (107 articles, last 24 months); community-reported acceptance: easy; 113 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE is published by Elsevier Masson and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Schizophrenia research and treatment, Health, Medicine and Society and Psychoanalysis and Psychopathology Research, together about 29.7% of its articles. Its main subfields are Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)
Revue de psychiatrie clinique biologique et thérapeutiqueInternational Journal of French PsychiatryL'Encephale is a journal of General Psychiatry (Clinical Psychiatry and Psychopharmacology). Initially dedicated to French speaking world, for five years L'Encephale has opened its submitting process to English speaking papers. Now it has become the International Journal of French Psychiatry.This journal with an Open Access option aims to provide state-of-the art research and policy updates and to stimulate discussion and debate amongst clinicians, research scientists and patient advocates in psychiatry, mental health, behavioral science, and neuroscience. L'Encephale is committed to publishing the latest advances in the full range of issues related to mental health including new developments in diagnosis and treatment, and advances in the biological underpinnings of mental, behavioral and cognitive function in clinical and general population samples.
From the journal's Aims & Scope
Research area (LetPub): Psychiatry
Editor-in-chief Raphaël GaillardPublisher website
Editorial board by country: none in mainland China; most named France 43, Egypt 2 (45 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Schizophrenia research and treatmentMedicine15.3%
- Health, Medicine and SocietyHealth Professions7.5%
- Psychoanalysis and Psychopathology ResearchPsychology6.9%
- Bipolar Disorder and TreatmentMedicine6.6%
- Mental Health and PsychiatryArts and Humanities6.2%
- Treatment of Major DepressionMedicine4.6%
- Psychosomatic Disorders and Their TreatmentsMedicine3.8%
- Mental Health Treatment and AccessPsychology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Neurosciences | Zone 4 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Neurosciences | Zone 4 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Neurosciences | Zone 4 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.18LetPub ·
- Impact factor (publisher)
- 1.3Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- CiteScore (publisher)
- 2.4Publisher website ·
- SJR 2026-06
- 0.45LetPub ·
- SNIP 2026-06
- 0.65LetPub ·
- h-index
- 43LetPub ·
- h-index
- 58OpenAlex ·
- i10-index
- 782OpenAlex ·
- 2-year mean citedness
- 1.23OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 14.34%LetPub ·
Volume
- Articles per year
- 100LetPub ·
Articles by year OpenAlex count · 3,228 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 122 | 51 | 45 |
| 2025 | 113 | 41 | 95 |
| 2024 | 123 | 60 | 300 |
| 2023 | 115 | 58 | 402 |
| 2022 | 127 | 70 | 440 |
| 2021 | 152 | 87 | 897 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
102 daysMedian, submission to acceptance · P25–P75 53 days – 179 days
- Acceptance to online
- median 90 days (104 articles)
- Submission to online
- median 193 days
- Sample
- 107 articles with submission and acceptance dates (297 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 40%Publisher website ·
- Submission to acceptance
- 115 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,240 / EUR 2,040 / GBP 1,790 / JPY 277,830 | — | — | |
| Publisher website | USD 2,240 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 2,240 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Masson
- Country or region
- FRANCE
- Language
- Multi-Language
- Frequency
- Bimonthly
- Founded
- 1906
- ISSN
- 0013-7006
- Electronic ISSN
- 2589-4935
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
What CAS zone is ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE in?
In the 2025 upgraded edition of the CAS Journal Ranking, ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE is in Zone 4 of Medicine, and in Zone 4 of the minor category Neurosciences / Psychiatry. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE?
The latest impact factor listed by LetPub is 1.18; CiteScore 2.4, h-index 58.
How long does peer review take at ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 102 days (interquartile range 53–179 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 40%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE based?
Of the 45 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (43) and Egypt (2). Counted from the institutions listed on the board page; for reference only.
Which databases index ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE?
According to LetPub and DOAJ records, ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE is indexed in SCIE and Scopus.
Is ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE open access, and what is the APC?
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE is a hybrid journal. For open-access publication: APC about USD 2,240.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .